← All trials
NCT00333385
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2001
- Primary completion
- —
- Completion date
- Apr 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Association Nationale pour les Traitements A Domicile, les Innovations et la RechercheLead sponsor
- GlaxoSmithKlineCollaborator
- Vaincre la MucoviscidoseCollaborator
- BaxaltaCollaborator
- RocheCollaborator
- University of ParisOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.